SHEN, QIANWEI
SHEN, QIANWEI
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.005 secondi).
Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
2018-01-01 Kallupi, Marsida; Shen, Qianwei; de Guglielmo, Giordano; Yasuda, Dennis; Journigan, V. Blair; Zaveri, Nurulain T; Ciccocioppo, Roberto
Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
2017-01-01 Shen, Qianwei; Deng, Yulin; Ciccocioppo, Roberto; Cannella, Nazzareno
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
2024-01-01 Cannella, Nazzareno; Lunerti, Veronica; Shen, Qianwei; Li, Hongwu; Benvenuti, Federica; Soverchia, Laura; Narendran, Rajesh; Weiss, Friedbert; Ciccocioppo, Roberto
NOP receptor agonist RO 64-6198 decreases escalation of cocaine self-administration in rats genetically selected for alcohol preference
2019-01-01 Li, H.; Scuppa, G.; Shen, Q.; Masi, A.; Nasuti, C.; Cannella, N.; Ciccocioppo, R.
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission
2021-01-01 Ciccocioppo, R.; De Guglielmo, G.; Li, H. W.; Melis, M.; Caffino, L.; Shen, Q.; Domi, A.; Fumagalli, F.; Demopulos, G. A.; Gaitanaris, G. A.
| Titolo | Data di pubblicazione | Autore(i) | Tipo | File |
|---|---|---|---|---|
| Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption | 1-gen-2018 | Kallupi, Marsida; Shen, Qianwei; de Guglielmo, Giordano; Yasuda, Dennis; Journigan, V. Blair; Zaveri, Nurulain T; Ciccocioppo, Roberto | Articolo | |
| Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors | 1-gen-2017 | Shen, Qianwei; Deng, Yulin; Ciccocioppo, Roberto; Cannella, Nazzareno | Articolo | |
| Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy | 1-gen-2024 | Cannella, Nazzareno; Lunerti, Veronica; Shen, Qianwei; Li, Hongwu; Benvenuti, Federica; Soverchia, Laura; Narendran, Rajesh; Weiss, Friedbert; Ciccocioppo, Roberto | Articolo | |
| NOP receptor agonist RO 64-6198 decreases escalation of cocaine self-administration in rats genetically selected for alcohol preference | 1-gen-2019 | Li, H.; Scuppa, G.; Shen, Q.; Masi, A.; Nasuti, C.; Cannella, N.; Ciccocioppo, R. | Articolo | |
| Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission | 1-gen-2021 | Ciccocioppo, R.; De Guglielmo, G.; Li, H. W.; Melis, M.; Caffino, L.; Shen, Q.; Domi, A.; Fumagalli, F.; Demopulos, G. A.; Gaitanaris, G. A. | Articolo |